Inventor · disambiguated record
Xia Wang
Also filed as: WANG XIA
16 granted patents·18 pending applications·271 citations·filing 2004–2025
92Inventor score
Top patents by PatentIndex Score
34 records- 0196US7745437B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2005·Granted Jun 29, 2010·83 cites·8 claims
- 0296US7642255B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2008·Granted Jan 5, 2010·60 cites·6 claims
- 0395US10421817B1Antibodies binding human Claudin 18.2 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Sep 24, 2019·33 cites·19 claims
- 0491US8202876B2Compounds and compositions as protein kinase inhibitorsALBAUGH PAMELA·Filed 2007·Granted Jun 19, 2012·39 cites·9 claims
- 0584US7371750B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted May 13, 2008·21 cites·7 claims
- 0683US7423038B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2005·Granted Sep 9, 2008·7 cites·7 claims
- 0781US7151096B2Cyclic compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Dec 19, 2006·15 cites·8 claims
- 0880US7846923B2Compounds and compositions as protein kinase inhbitorsIRM LLC·Filed 2007·Granted Dec 7, 2010·5 cites·6 claims
- 0975US8026243B2[4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitorsNOVARTIS AG·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 1074US8426404B2Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitorsZHANG GUOBAO·Filed 2006·Granted Apr 23, 2013·6 cites·15 claims
- 1168US2025114481A1Lentiviral vector for overexpressing egf, recombinant stem cell, and use thereofCENTRE FOR REGENERATIVE MEDICINE AND HEALTH HONG KONG INST OF SCIENCE & INNOVATION CHINESE·Filed 2024·Application pending·0 cites
- 1265US12098410B1Recombinant Zymomonas mobilis for producing ethylene glycol, method and uses thereofUNIV HUBEI·Filed 2023·Granted Sep 24, 2024·0 cites·3 claims
- 1365US2025121031A1Egf-rich exosomes, preparation method and use thereofCENTRE FOR REGENERATIVE MEDICINE AND HEALTH HONG KONG INST OF SCIENCE & INNOVATION CHINESE AC·Filed 2024·Application pending·0 cites
- 1464US2024094211A1Compositions and methods targeting s100a10 for the treatment and diagnosis of liver cancerUNIV HONG KONG·Filed 2023·Application pending·0 cites
- 1561US2024182460A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1658US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1755US2025277054A1Psma antibodies and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2025·Application pending·0 cites
- 1855US2024376194A1D3-binding molecules and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1952US8178526B2Compounds and compositions as ITPKb inhibitorsBURSULAYA BADRY·Filed 2008·Granted May 15, 2012·0 cites·7 claims
- 2051US2021127712A1Lactobacillus rhamnosus strain 753 and uses thereof, silage additive and silageUNIV SICHUAN AGRICULTURAL·Filed 2020·Application pending·0 cites
- 2150US2011263610A1Compounds and compositions as itpkb inhibitorsIRM LLC·Filed 2009·Application pending·0 cites
- 2247US11230472B2Method and apparatus for capturing carbon dioxide and producing sulfuric acid by sodium bisulfatePINGXIANG HUAXING ENV PROT ENG TECH CO LTD·Filed 2020·Granted Jan 25, 2022·0 cites·13 claims
- 2346US2009069327A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 2444US9290769B2Nitrogen fixation gene island suitable for expressing in prokaryotic and eukaryotic systemsWANG XIA·Filed 2012·Granted Mar 22, 2016·0 cites·13 claims
- 2544US2009076064A1CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2644US2008188483A1Compounds and Compositions as Protein Kinase InhibitorsIRM LLC·Filed 2006·Application pending·0 cites
- 2743US2009105250A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Application pending·0 cites
- 2843US2023364059A1Stable pharmaceutical compositionSimcere pharmaceutical co ltd·Filed 2021·Application pending·0 cites
- 2941US11306095B2Use of pteridinone derivative serving as EGFR inhibitorUNIV EAST CHINA SCIENCE & TECH·Filed 2016·Granted Apr 19, 2022·0 cites·11 claims
- 3041US2012202782A1Compounds and compositions as itpkb inhibitorsBURSULAYA BADRY·Filed 2012·Application pending·0 cites
- 3140US2009306039A1Compounds and compositions as itpkb inhibitorsPAN SHIFENG·Filed 2007·Application pending·0 cites
- 3239US9181238B2N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitorsPAN SHIFENG·Filed 2011·Granted Nov 10, 2015·0 cites·11 claims
- 3339US2008269275A1Novel Mchr1 Antagonists and Their Use for the Treatment of Mchr1 Mediated Conditions and DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3431US2012094995A12-aza-bicyclo[2.2.1]heptane compounds and uses thereofALBERT JEFFREY SCOTT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xia Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →